Swiss National Bank Axogen, Inc. Transaction History

Swiss National Bank

$137 Billion
Q1 2025

A detailed history of Swiss National Bank transactions in Axogen, Inc. stock. As of the latest transaction made, Swiss National Bank holds 81,000 shares of AXGN stock, worth $909,630. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,000

Holding current value

$909,630

% of portfolio

0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$14.56 - $20.11 $1.18 Million - $1.63 Million	81,000 New	81,000 $1.5 Million
Q3 2023 Nov 08, 2023	BUY	$4.68 - $9.26 $14,040 - $27,780	3,000 Added 3.46%	89,689 $448,000
Q1 2023 May 10, 2023	SELL	$7.53 - $10.95 $77,559 - $112,784	-10,300 Reduced 10.62%	86,689 $819,000
Q4 2022 Feb 08, 2023	BUY	$9.44 - $13.09 $915,576 - $1.27 Million	96,989 New	96,989 $967,000
Q2 2022 Aug 09, 2022	SELL	$6.99 - $10.0 $652,167 - $933,000	-93,300 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$7.26 - $10.7 $59,532 - $87,740	8,200 Added 9.64%	93,300 $741,000
Q2 2021 Aug 06, 2021	BUY	$17.8 - $23.5 $46,280 - $61,100	2,600 Added 3.15%	85,100 $1.84 Million
Q1 2021 May 07, 2021	BUY	$17.18 - $22.6 $24,052 - $31,640	1,400 Added 1.73%	82,500 $1.67 Million
Q2 2020 Aug 05, 2020	BUY	$7.35 - $10.81 $89,670 - $131,882	12,200 Added 17.71%	81,100 $749,000
Q1 2020 May 08, 2020	BUY	$8.38 - $17.34 $10,894 - $22,542	1,300 Added 1.92%	68,900 $717,000
Q4 2019 Feb 06, 2020	BUY	$11.18 - $18.6 $26,832 - $44,640	2,400 Added 3.68%	67,600 $1.21 Million
Q2 2019 Aug 02, 2019	BUY	$18.5 - $25.47 $98,050 - $134,991	5,300 Added 8.85%	65,200 $1.29 Million
Q1 2019 May 10, 2019	BUY	$14.62 - $22.13 $33,626 - $50,899	2,300 Added 3.99%	59,900 $1.26 Million
Q4 2018 Feb 13, 2019	BUY	$17.09 - $38.25 $17,090 - $38,250	1,000 Added 1.77%	57,600 $1.18 Million
Q3 2018 Nov 08, 2018	BUY	$34.05 - $55.9 $149,820 - $245,960	4,400 Added 8.43%	56,600 $2.09 Million
Q2 2018 Aug 09, 2018	BUY	$36.15 - $52.5 $101,220 - $147,000	2,800 Added 5.67%	52,200 $2.62 Million
Q1 2018 May 04, 2018	BUY	$24.4 - $40.25 $26,840 - $44,275	1,100 Added 2.28%	49,400 $1.8 Million
Q4 2017 Feb 07, 2018	BUY	$18.5 - $28.6 $893,550 - $1.38 Million	48,300	48,300 $1.37 Million

Others Institutions Holding AXGN

# of Institutions

191

Shares Held

39.2M

Call Options Held

61.7K

Put Options Held

42.8K

First Light Asset Management, LLC Edina, MN

4.47M
Shares

$50.2 Million
10.62% of portfolio
Black Rock Inc. New York, NY

3.25M
Shares

$36.5 Million
0.0% of portfolio
Morgan Stanley New York, NY

2.6M
Shares

$29.2 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.54M
Shares

$28.5 Million
0.0% of portfolio
Arrow Mark Colorado Holdings LLC Denver, CO

1.59M
Shares

$17.9 Million
0.54% of portfolio

View Full List

About Axogen, Inc.

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $475M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

More about AXGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account